46 results match your criteria: "University of Sydney and Northern Sydney Local Health District[Affiliation]"
J Eval Clin Pract
February 2025
Kolling Institute, Faculty of Medicine and Health, The University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Australia.
Rationale: The Drug Burden Index (DBI) measures exposure to anticholinergic and sedative drugs, which are associated with harm in older adults. To facilitate deprescribing in older Australian inpatients, we piloted an intervention bundle integrating the DBI in Electronic Medical Records, clinician deprescribing guides, consumer information leaflets and a stewardship pharmacist.
Objectives: To understand (i) hospital clinician experiences of using the bundle and (ii) consumer (patient and carer) and General Practitioner (GP) experiences of in-hospital deprescribing, following bundle implementation.
Adv Exp Med Biol
November 2024
Department of Neurosurgery, Alfred Hospital, Melbourne, VIC, Australia.
Br J Clin Pharmacol
January 2025
Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Australas J Ageing
October 2024
Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.
Objectives: To identify the prevalence of and factors associated with medication use in people living with dementia in the community.
Methods: A cross-sectional study using baseline data from a randomised controlled trial known as the Interdisciplinary Home-bAsed Reablement Program (I-HARP) between 2018 and 2021 in Sydney, Australia. Participants included people with mild-moderate dementia and their carers.
Diabetes Care
October 2024
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA.
Objective: To examine the association between preventive drug lists (PDLs) and changes in medication costs among patients with diabetes insured in commercial health plans over 2 follow-up years.
Research Design And Methods: We conducted a quasiexperimental study using the Optum deidentified Clinformatics Data Mart Database (January 2003 to December 2017). The intervention group included 5,582 patients with diabetes age 12-64 years switched by employers to PDL coverage; the control group included 5,582 matched patients whose employers offered no PDL.
Drugs Aging
October 2024
Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Background: Older inpatients with dementia are at an increased risk of an adverse drug reaction (ADR) during hospitalization.
Objective: To quantify the prevalence of ADRs in older inpatients according to dementia status and ADR definition approach and to identify risk factors of ADRs during hospitalization.
Methods: This was a retrospective cohort study of 2000 inpatients aged ≥ 75 years admitted consecutively to six Sydney hospitals (1 July 2016 to 31 May 2017).
Australas J Ageing
December 2024
Australian Frailty Network, The University of Queensland, Brisbane, Queensland, Australia.
Frailty is an important concept in the care of older adults. Over the past two decades, significant advances have been made in measuring frailty. While it is now well-recognised that frailty status is an important determinant of outcomes from medical illnesses or surgical interventions, frailty measurement is not currently routinely integrated into clinical practice.
View Article and Find Full Text PDFBr J Clin Pharmacol
January 2025
Centre for Education and Research on Ageing, Concord Hospital, Concord, Sydney, Australia.
Deprescribing is an evidence-based intervention to reduce potentially inappropriate medication use. Yet its implementation faces barriers including inadequate resources, training and time. Mobile applications (apps) on app stores could address some barriers by offering educational content and interactive features for medication assessment and deprescribing guidance.
View Article and Find Full Text PDFDrugs Aging
August 2024
Kolling Institute, The University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia.
With ageing of the population worldwide and discovery of new medications for prevention and management of age-related conditions, there is increasing use of medications by older adults. There are international efforts to increase the representativeness of participants in clinical trials to match the intended real-world users of the medications across a range of characteristics including age, multimorbidity, polypharmacy and frailty. Currently, much of the data on medication-related harm in older adults are from pharmacovigilance studies.
View Article and Find Full Text PDFParkinsonism Relat Disord
July 2024
Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Department of Neurology, Concord Repatriation General Hospital, Sydney, NSW, Australia; Molecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, NSW, Australia; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia. Electronic address:
Semin Thromb Hemost
October 2024
Genomics and Inherited Disease Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
J Gerontol A Biol Sci Med Sci
August 2024
Department of Life Sciences & Centre for Therapeutic Innovation, University of Bath, Bath, UK.
Background: Older adults (≥65 years) account for a disproportionately high proportion of hospitalization and in-hospital mortality, some of which may be avoidable. Although machine learning (ML) models have already been built and validated for predicting hospitalization and mortality, there remains a significant need to optimize ML models further. Accurately predicting hospitalization may tremendously affect the clinical care of older adults as preventative measures can be implemented to improve clinical outcomes for the patient.
View Article and Find Full Text PDFJ Am Geriatr Soc
September 2024
International Union of Basic and Clinical Pharmacology (IUPHAR) Geriatric Committee, Brentwood, Tennessee, USA.
The International Union of Basic and Clinical Pharmacology (IUPHAR) Geriatric Committee aims to improve the use of drugs in older adults and develop new therapeutic approaches for the syndromes and diseases of old age through advocacy, education, and research. In the present paper, we propose strategies relevant to drug development and evaluation, spanning preclinical and the full range of clinical studies. Drugs for older adults need to consider not only age, but also other characteristics common in geriatric patients, such as multimorbidity, polypharmacy, falls, cognitive impairment, and frailty.
View Article and Find Full Text PDFImplement Sci
March 2024
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC, 3052, Australia.
Introduction: Clinical practice guidelines recommend against the routine use of psychotropic medications in residential aged care facilities (RACFs). Knowledge brokers are individuals or groups who facilitate the transfer of knowledge into practice. The objective of this trial is to evaluate the effectiveness and cost-effectiveness of using knowledge brokers to translate Australia's new Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care.
View Article and Find Full Text PDFTremor Other Hyperkinet Mov (N Y)
January 2024
Translational Neurogenomics Group, Neurology Department & Molecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, NSW, Australia.
Expert Rev Clin Pharmacol
January 2024
Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, Sydney, NSW, Australia.
Introduction: This is a systematic review of prescribing, clinical, patient-reported, and health utilization outcomes of goal-directed medication reviews in older adults.
Methods: A systematic review was conducted using MEDLINE, EMBASE, SCOPUS and CINAHL databases to identify studies examining outcomes of goal-directed medication reviews in humans, with mean/median age ≥ 60 years and in English.
Results: Seventeen out of 743 articles identified were included.
Eur Spine J
January 2024
Faculty of Medicine and Health, Sydney Musculoskeletal Health, School of Health Sciences, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
J Am Geriatr Soc
December 2023
Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.
Eur Spine J
February 2024
Faculty of Medicine and Health, Sydney Musculoskeletal Health, School of Health Sciences, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
Purpose: People who seek more care for low back pain (LBP) tend to experience poorer recovery (e.g. higher pain and disability levels).
View Article and Find Full Text PDFDrugs Aging
April 2023
The University of Sydney, Sydney Musculoskeletal Health and Kolling Institute, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Level 10, Kolling Building, Gamaragal Country, St Leonards, Sydney, NSW, 2065, Australia.
Introduction: Globally, the rate of opioid prescription is high for chronic musculoskeletal conditions despite guidelines recommending against their use as their adverse effects outweigh their modest benefit. Deprescribing opioids is a complex process that can be hindered by multiple prescriber- and patient-related barriers. These include fear of the process of, or outcomes from, weaning medications, or a lack of ongoing support.
View Article and Find Full Text PDFMicrobiome
March 2023
Charles Perkins Centre, The University of Sydney, Camperdown, Sydney, NSW, Australia.
Background: Unrevealing the interplay between diet, the microbiome, and the health state could enable the design of personalized intervention strategies and improve the health and well-being of individuals. A common approach to this is to divide the study population into smaller cohorts based on dietary preferences in the hope of identifying specific microbial signatures. However, classification of patients based solely on diet is unlikely to reflect the microbiome-host health relationship or the taxonomic microbiome makeup.
View Article and Find Full Text PDFBMC Public Health
March 2023
Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia.
Open Forum Infect Dis
February 2023
National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.
Background: Management of infections remains challenging. We described predisposing factors, clinical manifestations, and outcomes of these rare mold infections, including predictors of early (1-month) and late (18-month) all-cause mortality and treatment failure.
Methods: We conducted a retrospective Australian-based observational study of proven/probable infections from 2005 to 2021.
BMC Public Health
January 2023
Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia.
Background: In 2020, the World Health Organization (WHO) released the first global physical activity and sedentary behaviour guidelines for children and adults living with disability. The evidence informing the guidelines though is not specific to people living with traumatic brain injury (TBI), but rather comes from other disabling conditions such as Parkinson's disease, and stroke. There remains a clear lack of direct evidence of the effects of physical activity for people living with TBI.
View Article and Find Full Text PDF